Form 4: Phreesia SVP David Linetsky Reports Sale of Shares to Cover Tax Obligations

David Linetsky, SVP of Life Sciences at Phreesia, Inc., reported the sale of 260 shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On April 21, 2025, David Linetsky, SVP of Life Sciences at Phreesia, Inc., sold 260 shares of common stock.
• The sale was executed to cover tax withholding obligations related to the settlement of restricted stock units.
• The shares were sold at a weighted average price of $23.0418.
• The prices ranged from $22.75 to $23.675 per share.
• Following the transaction, Linetsky directly owns 217,239 shares and indirectly owns 8,752 shares through a spouse.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction for tax purposes and doesn't necessarily reflect a change in the executive's confidence in the company.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the transactions of company insiders. This filing indicates a standard sell-to-cover transaction to meet tax obligations.

Stakeholder Impact

• The sale of a small number of shares is unlikely to have a significant impact on shareholders.

Key Dates

Keywords

Form 4, Phreesia, Linetsky, Share Sale, Tax Obligations, Restricted Stock Units, Beneficial Ownership, Insider Trading